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Abstract
Pathogenic loss-of-function variants in SCN1B are linked to Dravet syndrome
(DS). Previous work suggested that neuronal pathfinding defects underlie
epileptogenesis and SUDEP in the Scn1b null mouse model of DS. We tested
this hypothesis by inducing Scn1b deletion in adult mice that had developed
normally. Epilepsy and SUDEP, which occur by postnatal day 21 in Scn1b null
animals, were observed within 20 days of induced Scn1b deletion in adult mice,
suggesting that epileptogenesis in SCN1B-DS does not result from defective
brain development. Thus, the developmental brain defects observed previously
in Scn1b null mice may model other co-morbidities of DS.
Introduction
Voltage gated sodium channels (VGSCs) are heterotri-
mers, composed of one pore-forming a subunit and two
nonpore-forming b subunits.1 b1 subunits are ubiqui-
tously expressed throughout the nervous system with
wide subcellular localization in neurons where they asso-
ciate with many, if not all, VGSC a subunits.2 b1 subunits
regulate VGSC a subunit trafficking, expression, and gat-
ing, associate with and modulate some voltage-gated
potassium channels, and play nonconducting roles in
neuronal pathfinding and fasciculation as immunoglobu-
lin superfamily cell adhesion molecules (Ig-CAMs).2
Variants in VGSC genes are linked to the developmen-
tal and epileptic encephalopathies (DEEs).3 Dravet syn-
drome (DS) is a severe DEE predominantly linked to
haploinsufficiency of SCN1A, encoding the VGSC a sub-
unit Nav1.1. Results from mouse models suggest that epi-
lepsy in DS initiates from disinhibition through reduced
sodium current density in cortical and hippocampal par-
valbumin-positive GABAergic interneurons.4 While the
majority of DS patients have de novo, heterozygous vari-
ants in SCN1A, inherited, homozygous loss-of-function
variants in SCN1B, encoding the VGSC b1/b1B subunits,
also result in DS, or a DS-like DEE.5,6 Scn1b null mice
are a DS model, with severe seizures, ataxia, and 100%
lethality prior to weaning.5 Scn1b null mice have neuronal
pathfinding defects in brain that precede the onset of sei-
zures.7 Based on these results, we proposed that epilepsy
in this model is of neurodevelopmental origin due to the
loss of b1-mediated Ig-CAM function.7 In the related
Scn1b-p.C121W homozygous mouse model, which has a
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similar DS-like phenotype, neuronal hyperexcitability was
postulated to arise from the developmental loss of b1-me-
diated Ig-CAM function.8 In support of this hypothesis,
variants in other neurodevelopmental CAMs, for example,
protocadherin 7 and 19,3,8 are also associated with epi-
lepsy.
Because b1 subunits are multifunctional Ig-CAMs and
channel modulators, it is important to understand what
roles altered development play in epileptogenesis in
response to Scn1b loss-of-function. Here, we test the
hypothesis that altered neuronal development is necessary
for epileptogenesis in the Scn1b model of DS. We show
that severe seizures and SUDEP occur following Scn1b
deletion in adult mice that had developed normally, sug-
gesting that epileptogenesis in SCN1B-DS does not result
from defective brain development.
Methods
Animals
Experiments were performed in accordance with NIH
guidelines and approved by the University of Michigan
Institutional Animal Care and Use Committee. Scn1bFl/Fl
mice, on the C57BL/6J background,9 were crossed with
Slick-H mice (JAX Tg(Thy1-cre/ERT2,-EYFP)HGfng/
PyngJ, stock #012708) received on the (C57BL/6J x CBA)
F1 background and backcrossed to C57BL/6J, to generate
Slick-H/Scn1bFl/Fl and Slick-H/Scn1bE/E mice. Tamoxifen
(TMX, Sigma-Aldrich) was dissolved in sunflower oil +
2% ethanol at a final concentration of 10 lg/lL. 10 lL of
TMX solution or vehicle per g mouse weight were admin-
istered intraperitoneal (IP) once per day for 4 consecutive
days.
Immunohistochemistry
P60 Slick-H mice, treated with TMX 10 days prior, were
anesthetized with isoflurane and transcardially perfused
with ~10 mL of PBS followed by ~10 mL of 4%
paraformaldehyde (PFA). Tissues were postfixed overnight
in 4% PFA, then cryoprotected in 10% sucrose followed
by 30% sucrose overnight, flash frozen in 2-methylbutane,
and stored at 80°C. 20 lm coronal brain sections were
cut on a Leica cryostat and stored at 20°C until pro-
cessing for immunohistochemistry.
For immunohistochemistry, sections at the same loca-
tions relative to Bregma for each animal were dried and
postfixed for 10 min with 4% PFA, washed three times
for 5 min each with 0.05 mol/L phosphate buffer (PB),
and incubated in PBTGS blocking buffer (10% goat
serum, 0.3% Triton X-100, 0.1 mol/L PB) for ≥2 h in a
humidified chamber. Sections were then incubated with
primary antibodies (diluted in PBTGS) overnight in a
humidified chamber and washed 3 times for 10 min with
0.1 mol/L PB. Primary antibodies were anti-GABA (rab-
bit, Sigma-Aldrich, 1:400), anti-GFP (chicken, Invitrogen,
1:400), and anti-CTIP2 to identify cortical layer V/VI
neurons (rat, Abcam, 1:250). From this point forward, all
steps were performed in the dark to minimize photo-
bleaching of secondary antibodies. Sections were incu-
bated with goat anti-chicken AlexaFluor-488, goat anti-rat
AlexaFluor-647, and/or goat anti-rabbit AlexaFluor-594-
conjugated secondary antibodies (Invitrogen, diluted in
PBTGS) for 2 h, washed three times for 10 min in 0.1%
PB, incubated with DAPI for 20 min, dried, and then
coverslips were mounted using ProLong Gold anti-fade
reagent (Invitrogen).
Sections were imaged using a Nikon A1R confocal
microscope with Nikon NIS-Elements AR software
located in the UM Department of Pharmacology using a
20 9 0.75 NA dry objective. Confocal images spanning
10 lm were acquired at 0.9 lm intervals and flattened
using maximum signal for analysis. Images were pro-
cessed and analyzed using NIH-ImageJ, and figures were
assembled using Adobe Photoshop.
EEG Implantation
Slick-H/Scn1bFl/Fl, Slick-H negative/Scn1bFl/Fl, and Slick-H/
Scn1bE/E mice were implanted at P42 to 70 with 6 EEG
electrodes. For surgery, each mouse was anesthetized with
isoflurane or ketamine/xylazine and placed in a stereo-
taxic adapter. The electrodes were implanted over the left
and right front lobes, the left and right parietal lobes, the
cerebellum, and the sinus cavity using mounting screws.
The electrodes were connected to a 6-pin electrode pedes-
tal and the headcap was secured using dental cement.
After 7 days of recovery, simultaneous EEG recording and
video monitoring were performed on Ceegraph Vision;
Bio-logic System Corporation and Natus recording sys-
tems. Following baseline recording for 2 days, mice were
removed from recording for injection with TMX and
recording was resumed at 7 days postinitial TMX injec-
tion. Signals were acquired at 256 Hz with simultaneous
video monitoring. Data were filtered with a 1 Hz low pass
filter, a 70 Hz high pass filter, and a notch filter at 60 Hz.
Seizures were assessed manually.
Results
Scn1b null DS mice exhibit severe seizures beginning at
~postnatal day (P)10 and 100% lethality prior to ~P21.10
Our previous work suggested that aberrant brain develop-
ment due to loss of b1-mediated cell adhesion may
underlie epileptogenesis in this model.7 To test this
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Figure 1. Slick-H YFP expression in cortex, hippocampus, and subiculum. (A) Slick-H mice express Cre and a YFP reporter (green) in projection
neurons of the visual cortex with limited overlap with GABA+ cells (magenta). (B–E) Slick-H mice express Cre and a YFP reporter in projection
neurons of the hippocampus with limited overlap with GABA+ cells in the dentate gyrus (DG) (B), CA1 (C), CA3 (D), and subiculum (E). (F)
Quantification of overlap between YFP and GABA+ cells across cortical layers (left) and hippocampal regions (right). YFP+ cell density in DG, CA1,
and CA3 not quantified due to unclear cell boundaries with high density. Scale bars (in A and E) = 100 lm.
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hypothesis, we crossed Scn1bFl/Fl mice9 with a tamoxifen
(TMX)-inducible Thy1-Cre (Slick-H) strain.11 Slick-H
mice express Cre recombinase in response to TMX
administration in Thy1- expressing neurons, and are thus
useful for separation of locally projecting GABA-positive
(+) neurons from locally and nonlocally projecting excita-
tory neurons. Constitutive Thy1-driven YFP expression in
Slick-H mouse cortex showed laminar restriction within
Figure 2. Inducible deletion of Scn1b in adult projection neurons results in epilepsy and SUDEP. (A) Kaplan-Meier survival curve of Slick-H/
Scn1bFl/Fl mice injected with TMX at P14–19 (n = 5) or P42–117 (n = 15) compared to control mice: P14–19 Slick-H/Scn1bE/E adolescent (n = 4)
and Slick-H negative Scn1bFl/Fl P42–117 mice (n = 7). Survival of adult and adolescent Slick-H/Scn1bFl/Fl mice following TMX administration was
not different (P = 0.71, Mantel-Cox test). All Slick-H/Scn1bFl/Fl mice treated with TMX exhibited numerous behavioral seizures. (B) TMX-induced
Scn1b deletion in adult mice results in behavioral and electrographic seizures within 8 days of initial TMX administration. Control mice (black,
n = 4) exhibited no seizures throughout the experiment while Slick-H/Scn1bFl/Fl mice that were administered TMX (blue squares, circles, and
triangles represent individual mice; n = 3) experienced as many as 60 seizures/day. Slick-H mice were euthanized at days 8, 9, and 20 due to
morbidity. (C) Representative EEG traces of Slick-H/Scn1bFl/Fl and Slick-H/Scn1bE/E mice. Left(L)/Right(R) and Frontal(F)/Parietal(P) screw electrode
placement. Scale bar = 2000 lV and 3 sec. (D) Expanded time scale of traces in panel C showing seizure onset. Scale bar = 2000 lV and
0.25 sec.
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pyramidal neurons of layers 3, 5, and 6 (Fig. 1A), as
shown previously.11 We co-stained with anti-GABA to
examine whether GABA+ neurons are also targeted by
Thy1 promoter-driven Cre recombinase in this strain.
Neurons that were YFP+ were seldom GABA+ and vice
versa (Fig. 1A, B, and F). We found similar results within
the hippocampus, with dense labeling of the dentate gyrus
and pyramidal neurons throughout the CA1, CA2, and
CA3 regions, as well as in the subiculum, with limited
overlap of YFP+ and GABA+ neurons (Fig. 1C and D).
To investigate the developmental dependence of epi-
lepsy and SUDEP in response to Scn1b deletion, we
administered TMX to Slick-H/Scn1bFl/Fl mice over various
time ranges (P14–19, P42–117, and P > 100) to ask
whether induced Scn1b deletion in adult mice that had
developed normally resulted in seizures and death.
Regardless of age of administration, TMX treatment
resulted in severe epilepsy and death in 100% of Slick-H/
Scn1bFl/Fl mice compared to controls (Slick-H negative
Scn1bFl/Fl mice injected with vehicle or Slick-H/Scn1bE/E
mice injected with TMX) within 20 days (Fig. 2A). All
TMX-treated Slick-H/Scn1bFl/Fl mice exhibited frequent
spontaneous, behavioral seizures. To verify epileptic activ-
ity electrographically, we implanted three Slick-H/Scn1bFl/
Fl mice, two Slick-H/Scn1bFl/Fl vehicle control mice and
two Slick-H negative Scn1bFl/Fl control mice with EEG
electrodes. Two days of baseline recording were followed
by one IP administration of TMX or vehicle per day for
four consecutive days to delete Scn1b. EEG recording was
resumed 7 days after the initial TMX treatment (post-
TMX). We observed no seizures in Slick-H/Scn1bFl/Fl or
control mice for the duration of baseline recording. In
the Slick-H/Scn1bFl/Fl group, seizures were detected as
early as 7 days post-TMX (Fig. 2B and C). Two mice
exhibited severe epilepsy and were euthanized for ethical
reasons at day 8 and 9, respectively. The third mouse had
a more gradual increase in seizure severity and was eutha-
nized at 20 days post-TMX due to morbidity. These
results demonstrate that, although developmental brain
defects are present in Scn1b-DS mice, epileptogenesis and
SUDEP are not the result of impaired brain development.
Discussion
The results of this study demonstrate that epileptogenesis
resulting from Scn1b loss-of-function is not due to
impaired neuronal development. Furthermore, our data
show that deletion of Scn1b in forebrain excitatory, but
not inhibitory, neurons recapitulates the DS phenotype in
mice. In previous work, targeted deletion of Scn1a in
mouse inhibitory neurons phenocopied DS.12 In contrast,
targeted deletion of Scn1a in excitatory neurons failed to
recapitulate the DS phenotype and instead ameliorated
disease severity when coupled with deletion in interneu-
rons.13 Importantly, our work demonstrates that diverse
mechanisms can lead to common neurological disease
phenotypes.
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